Diabetes Insights - Breakthroughs and Innovators

The EASD’s first clinical practice guideline on the assessment and management of diabetes distress in adults living with type 1 or type 2 diabetes has now been published in Diabetologia.

Drawing on two years of multidisciplinary work, the guideline was developed by clinicians, methodologists, psychologists and people with lived experience. Prof. Jane Speight, Prof. Richard Holt and patient-advocate Michelle Law describe what diabetes distress is (the emotional burden tied to daily self-management) and why routine assessment and supportive care must become part of standard practice.

The conversation explores the definition of diabetes distress, evidence gaps, assessment tools, psychological interventions and...

How can people living with diabetes help shape the future of diabetes care?

In this episode of the EASD Podcast, recorded at the EASD Annual Meeting, Vivienne Parry is joined by Bastian Hauck and Renza Scibilia from the Diabetes Online Community (Dedoc).

Together, they discuss some of the key issues facing people living with type 1 diabetes today, including emerging off-label therapies such as GLP-1 receptor agonists, advances in continuous glucose monitoring, responsible use of health data, and the ongoing effort to end diabetes stigma.

The conversation highlights why people with lived experience must be involved at every stage of...

In this episode, Dr Jeroen van der Velde explores one of the most common questions in lifestyle medicine: does the time of day you exercise make a difference?

Drawing on the latest research presented at the EASD Annual Meeting, he discusses how exercise timing may influence glycaemic control, the role of circadian rhythms in metabolic health, and why later-day exercise appears to offer benefits for people living with or at risk of type 2 diabetes. The conversation also examines chronotypes, shift work, meal timing and the importance of personalised lifestyle advice, while reinforcing the key message that regular physical activity...

In this episode, Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, and Rachel Connor, Director of Research Partnerships at Breakthrough T1D, discuss why prevention has become one of the biggest topics in type 1 diabetes research.

They explore how decades of charity-funded research have led to exciting advances in immunotherapies that can delay the onset of type 1 diabetes, the growing importance of early screening programmes, and the promise of stem cell-derived beta cell therapies. They also explain why collaboration between researchers, charities, healthcare professionals, policymakers and people living with diabetes will be essential to ensure these breakthroughs...